GAMMA Investing’s Praxis Precision Medicines PRAX Stock Holding History

GAMMA Investing’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$126K	Buy	432 +100	+30%	+$33.1K	﹤0.01%	1690
2026 Q2	$111K	Buy	332 +31	+10%	+$9.81K	﹤0.01%	1736
2026 Q1	$97K	Buy	301 +63	+26%	+$19.5K	﹤0.01%	1696
2025 Q4	$70.1K	Buy	238 +88	+59%	+$16.4K	﹤0.01%	1837
2025 Q3	$7.95K	Sell	150 -5	-3%	-$242	﹤0.01%	2985
2025 Q2	$6.52K	Buy	155 +49	+46%	+$1.87K	﹤0.01%	3016
2025 Q1	$4.01K	Buy	106 +41	+63%	+$2.56K	﹤0.01%	3172
2024 Q4	$5K	Buy	65 +39	+150%	+$2.82K	﹤0.01%	2919
2024 Q3	$1.5K	Buy	+26	New	+$1.41K	﹤0.01%	3150

Other funds holding PRAX

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's PRAX Position: Q3 2026 in Review

GAMMA Investing increased its Praxis Precision Medicines (PRAX) stake by 30% in Q3 2026, buying an estimated $33.1K and bringing the position to 432 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #1690.

GAMMA Investing first reported a position in PRAX in Q3 2024 and has held it in 9 quarters since. 4 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

GAMMA Investing held 432 shares of Praxis Precision Medicines worth $126K as of Q3 2026.
GAMMA Investing bought 100 Praxis Precision Medicines shares in Q3 2026, an estimated $33.1K.
Praxis Precision Medicines made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1690 holding.
GAMMA Investing first reported a position in Praxis Precision Medicines in Q3 2024 and has held it in 9 quarters since.
4 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.